Assignee
SANTEN PHARMACEUTICAL CO LTD
JP·221 granted patents·103 pending applications·2,050 citations·filing 1974–2025
Top patents by PatentIndex Score
324 records- 0195US9415038B2Pharmaceutical formulations comprising a pyridylaminoacetic acid compoundSANTEN PHARMACEUTICAL CO LTD·Filed 2015·Granted Aug 16, 2016·10 cites·15 claims
- 0295US8367097B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2010·Granted Feb 5, 2013·31 cites·14 claims
- 0395US7358255B2Therapeutic agent for keratoconjunctival disorderSANTEN PHARMACEUTICAL CO LTD·Filed 2004·Granted Apr 15, 2008·81 cites·6 claims
- 0495US4457935AAntihypertensive 4-thiazolidinecarboxylic acids (substituted phenyl derivatives)SANTEN PHARMACEUTICAL CO LTD·Filed 1981·Granted Jul 3, 1984·36 cites·32 claims
- 0594US8927005B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2013·Granted Jan 6, 2015·20 cites·20 claims
- 0693US11419880B2Ursodeoxycholic acid-containing agent for treating or preventing presbyopiaSANTEN PHARMACEUTICAL CO LTD·Filed 2021·Granted Aug 23, 2022·2 cites·9 claims
- 0791US9999594B2Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockageSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Granted Jun 19, 2018·4 cites·8 claims
- 0891US9539204B2Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockageSANTEN PHARMACEUTICAL CO LTD·Filed 2012·Granted Jan 10, 2017·7 cites·4 claims
- 0991US7438704B1Open instillation container and method of manufacturing the containerSANTEN PHARMACEUTICAL CO LTD·Filed 2000·Granted Oct 21, 2008·50 cites·9 claims
- 1090USRE48183EPharmaceutical formulations comprising a pyridylaminoacetic acid compoundSANTEN PHARMACEUTICAL CO LTD·Filed 2018·Granted Sep 1, 2020·2 cites·15 claims
- 1190US10702511B2Pharmaceutical formulations comprising a pyridylaminoacetic acid compoundSANTEN PHARMACEUTICAL CO LTD·Filed 2018·Granted Jul 7, 2020·2 cites·17 claims
- 1289US11331322B1Medicament for preventing and/or treating dry eyeSANTEN PHARMACEUTICAL CO LTD·Filed 2021·Granted May 17, 2022·2 cites·14 claims
- 1389US10435379B2[4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 8, 2019·5 cites·9 claims
- 1489US10189796B2[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 29, 2019·6 cites·26 claims
- 1588US12295946B2Pharmaceutical formulations comprising a pyridylaminoacetic acid compoundSANTEN PHARMACEUTICAL CO LTD·Filed 2023·Granted May 13, 2025·0 cites·16 claims
- 1688US12201602B2Medicament comprising combination of sepetaprost and Rho-associated coiled-coil containing protein kinase inhibitorSANTEN PHARMACEUTICAL CO LTD·Filed 2022·Granted Jan 21, 2025·1 cites·11 claims
- 1788US10179127B2Pharmaceutical formulations comprising a pyridylaminoacetic acid compoundSANTEN PHARMACEUTICAL CO LTD·Filed 2018·Granted Jan 15, 2019·4 cites·16 claims
- 1888US10149908B2Pharmaceutical composition containing pyridylaminoacetic acid compoundSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Granted Dec 11, 2018·7 cites·14 claims
- 1988US9943510B2Pharmaceutical formulations comprising a pyridylaminoacetic acid compoundSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Granted Apr 17, 2018·2 cites·15 claims
- 2087US9339496B2Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonistSANTEN PHARMACEUTICAL CO LTD·Filed 2013·Granted May 17, 2016·4 cites·17 claims
- 2187US5736546A1,4-(diphenlyalkyl) piperazine derivativesSANTEN PHARMACEUTICAL CO LTD·Filed 1994·Granted Apr 7, 1998·51 cites·22 claims
- 2286US10632139B2Ophthalmic solution comprising diquafosolSANTEN PHARMACEUTICAL CO LTD·Filed 2018·Granted Apr 28, 2020·2 cites·10 claims
- 2386US4786635ANovel benzothiazine derivativesSANTEN PHARMACEUTICAL CO LTD·Filed 1986·Granted Nov 22, 1988·22 cites·17 claims
- 2485US5891912A1,3-dialkylurea derivatives having a hydroxyl groupSANTEN PHARMACEUTICAL CO LTD·Filed 1995·Granted Apr 6, 1999·34 cites·28 claims
- 2585US4305958ACysteine derivativesSANTEN PHARMACEUTICAL CO LTD·Filed 1977·Granted Dec 15, 1981·20 cites·4 claims
- 2684US7491739B2TNF-α production inhibitorsSANTEN PHARMACEUTICAL CO LTD·Filed 2006·Granted Feb 17, 2009·5 cites·9 claims
- 2784US7455855B2Delivering substance and drug delivery system using the sameSANTEN PHARMACEUTICAL CO LTD·Filed 2001·Granted Nov 25, 2008·22 cites·12 claims
- 2884US7345064B2TNF-α production inhibitorsSANTEN PHARMACEUTICAL CO LTD·Filed 2006·Granted Mar 18, 2008·5 cites·12 claims
- 2984US6420398B2Urea derivatives having nitrogen aromatic heterocycleSANTEN PHARMACEUTICAL CO LTD·Filed 2001·Granted Jul 16, 2002·16 cites·23 claims
- 3083US11707577B2Accurate, precise microliter dosing syringeSANTEN PHARMACEUTICAL CO LTD·Filed 2017·Granted Jul 25, 2023·4 cites·27 claims
- 3183US11612590B2Therapeutic agent for meibomian dysfunctionSANTEN PHARMACEUTICAL CO LTD·Filed 2019·Granted Mar 28, 2023·1 cites·3 claims
- 3283US10071113B2Ophthalmic solution comprising diquafosolSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Granted Sep 11, 2018·4 cites·11 claims
- 3383US9387165B2Rapamycin formulations and methods of their useSANTEN PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 12, 2016·3 cites·7 claims
- 3483US5968980A1,3-dialkylurea derivativeSANTEN PHARMACEUTICAL CO LTD·Filed 1995·Granted Oct 19, 1999·39 cites·40 claims
- 3583US5707643ABiodegradable scleral plugSANTEN PHARMACEUTICAL CO LTD·Filed 1996·Granted Jan 13, 1998·389 cites·17 claims
- 3683US4224457AProcess for manufacturing optically active sulfur-containing carboxylic acidSANTEN PHARMACEUTICAL CO LTD·Filed 1979·Granted Sep 23, 1980·15 cites·17 claims
- 3783US2024245668A1Agent for treating or preventing glaucoma including a sulfonamide compound and another drugSANTEN PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 3882US11666563B2Pharmaceutical preparation containing pyridyl aminoacetic acid compoundSANTEN PHARMACEUTICAL CO LTD·Filed 2018·Granted Jun 6, 2023·1 cites·10 claims
- 3982US11166974B2Ophthalmic solution comprising DiquafosolSANTEN PHARMACEUTICAL CO LTD·Filed 2020·Granted Nov 9, 2021·1 cites·10 claims
- 4082US11013731B2Intratumoral administration of sirolimus for treatment of prostate cancerSANTEN PHARMACEUTICAL CO LTD·Filed 2017·Granted May 25, 2021·5 cites·19 claims
- 4182US6492370B1Urea derivatives and pharmaceutical compositions thereofSANTEN PHARMACEUTICAL CO LTD·Filed 1999·Granted Dec 10, 2002·22 cites·5 claims
- 4282US4479949ABenzothiazoline compoundsSANTEN PHARMACEUTICAL CO LTD·Filed 1982·Granted Oct 30, 1984·17 cites·14 claims
- 4382US4241086AMethod for treating rheumatismSANTEN PHARMACEUTICAL CO LTD·Filed 1979·Granted Dec 23, 1980·17 cites·2 claims
- 4482US2024024484A1Pharmaceutical composition containing pyridylaminoacetic acid compoundSANTEN PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 4582US2025235439A1Pharmaceutical formulations comprising a pyridylaminoacetic acid compoundSANTEN PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 4681US11951098B2Therapeutic agent for meibomian dysfunctionSANTEN PHARMACEUTICAL CO LTD·Filed 2023·Granted Apr 9, 2024·0 cites·12 claims
- 4781US8030349B2Method for prevention of degradation of thermally unstable medicamentSANTEN PHARMACEUTICAL CO LTD·Filed 2006·Granted Oct 4, 2011·1 cites·1 claims
- 4881US4584300APlatelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use thereforSANTEN PHARMACEUTICAL CO LTD·Filed 1984·Granted Apr 22, 1986·13 cites·19 claims
- 4981US4496578AAntihypertensive sulfur-containing compoundsSANTEN PHARMACEUTICAL CO LTD·Filed 1982·Granted Jan 29, 1985·11 cites·9 claims
- 5081US4483861AAntihypertensive sulfur-containing compoundsSANTEN PHARMACEUTICAL CO LTD·Filed 1979·Granted Nov 20, 1984·9 cites·17 claims
Showing the top 50 of 324 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SANTEN PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →